ltraviolet Light (UV) Therapy for Atopic Dermatitis: Double blind, randomised trial of narrow band (TLO1) versus UVA versus placebo.
Completed
- Conditions
- Skin and connective tissue diseases:Skin and Connective Tissue DiseasesAtopic Dermatitis
- Registration Number
- ISRCTN10725589
- Lead Sponsor
- HS R&D Regional Programme Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 75
Inclusion Criteria
Patients, aged 16-65 years with moderate severe atopic dermatitis.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preliminary work suggests a response should be detectable after 12 treatments. Physical signs of disease activity, overall extent of disease, patient symptoms and quantities of topical steroids used will be assessed, by an observer who is unaware of treatment received, at baseline, after 6, 12, 18 and 24 treatments and 3 months after stopping phototherapy.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration